The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

Also called NCT03170349

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 124 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03170349
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Canada, Germany, Greece, Italy, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03170349. Allocation not applicable; no masking; primary purpose treatment. Start 2017-06-27 (actual); primary completion 2020-07-30 (actual). Results posted on 2021-12-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
Acronym
CLASP
Condition
Mitral Valve Regurgitation
Intervention (Device)
Mitral Valve Repair
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct03170349
Content hash
dc9b6ffd4557fcf8758c3708434a234cd2a697943715499b8b67dd0825fe0083